Projects

Peritonitis rates in children on chronic peritoneal dialysis during COVID-19 pandemic- observations from an under-resourced region

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2021 - 2021

Project Lead

Dr. Nivedita Kamath

Authors

Dr. Nivedita Kamath, Mrs. Shaila Lobo, Dr. Arpana Iyengar

Project Status

completed